Neurol. praxi. 2020;21(1):68-70 | DOI: 10.36290/neu.2020.013

Autoimmune encephalitis? Not. False positivity of anti-NMDA antibodies in patient with Creutzfeldt-Jacob disease

MUDr. Barbora Sklenárová1,2, MUDr. Irena Doležalová, Ph.D.1
1 I. neurologická klinika, LF MU, FN u sv. Anny v Brně
2 Středoevropský technologický institut (CEITEC), Brno

Anti-NMDA encephalitis is one of many types of autoimunne encephalitis (AIE), about which we are thinking during diagnostic process even more in these days. Typical symptoms of AIE are loss of memory, epileptic seizures and psychiatric symptoms. During diagnostic process is important to find positivity of antibodies, in the case of anti-NMDA encephalitis there are antibodies against N-methyl-D-aspartate receptors, which are placed on almost all neurons in the brain and spinal cord. Early diagnosis and treatment of this disease is an important prognostic factor. However there are some cases, in which there is no association between anti-NMDA antibodies and autoimunne encephalitis, as we can see in the following case report.

Keywords: anti-NMDA encephalitis, autoimunne encephalitis.

Received: February 22, 2020; Revised: February 22, 2020; Accepted: February 22, 2020; Prepublished online: February 22, 2020; Published: March 30, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sklenárová B, Doležalová I. Autoimmune encephalitis? Not. False positivity of anti-NMDA antibodies in patient with Creutzfeldt-Jacob disease. Neurol. praxi. 2020;21(1):68-70. doi: 10.36290/neu.2020.013.

Video 1

Video 2

Download citation

References

  1. Elišák M, Meluzínová E, Hanzalová J, Lišková P, Krýsl D, Doležalová I, Štětkářová I, Marusič P. Anti-NMDAR protilátky u demyelinizačních onemocnění. Cesk Slov Neurol N 2017; 80/113(3): 332-335. Go to original source...
  2. Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D, Cunningham R, Zuckerman M, Mutton KJ, Solomon T, Ward KN, Lunn MP, Irani SR, Vincent A, Brown DW, Crowcroft NS. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010; 10(12): 835-844. Go to original source... Go to PubMed...
  3. Krýsl D. Autoimunitní encefalitidy. Neurol. praxi 2015; 16(6): 317-323.
  4. Rossi M, Mead S, Collinge J, Rudge P, Vincent A. Neuronal antibodies in patients with suspected or confirmed sporadic Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry Published Online First: 22 September 2014. doi: 10.1136/jnnp-2014-308695. Go to original source...
  5. Titulaer MJ, McCracken L, Gabilondo I, Armangué T, GlaserC, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld M, Balice-Gordon R, Graus F, Dalmau J. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. The Lancet Neurology 2013; 12(2): 157-165. Go to original source... Go to PubMed...
  6. Titulaer MJ, Hoftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, Benson LA, Shu H, Irioka T, Hirano M, Singh G, Cobo Calvo A, Kaida K, Morales PS, Wirtz PW, Yamamoto T, Reindl M, Rosenfeld MR, Graus F, Saiz A, Dalmau J. Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 2014; 75(3): 411-428. Go to original source...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.